In this study, we have demonstrated that human primary CLL cells generally express high level of CXCR4, and LY2624587 is able to block SDF-1 and CXCR4 mediated cell signaling and induce apoptosis of NHL and lymphoblastic leukemia cells in vitro. Here, CXCR4 is linked to B-cell chronic lymphocytic leukemia.